Toll Free: 1-888-928-9744

Global Insulin (Medication) Market Research Report to 2020

Published: Jun 23, 2016 | Pages: 121 | Publisher: QYResearch | Industry: Diabetes | Report Format: Electronic (PDF)

The global insulin market is estimated to grow at a CAGR of 8% during the forecast period, to reach USD 40 Billion by 2020. Although share less than 40% of diabetes market, insulins keep a higher increase rate. The share of insulin manufactures is highly concentrated. The top seven insulin drugs all come from three companies, whose total sales has reached USD 20 billion in 2015.
This report studies Insulin (Medication) in Global market, especially in USA, EU, China, Japan, Southeast Asia and India, focuses on top players in these countries, with sales, price, revenue and market share in Global market, like
Novo Nordisk (Denmark)
Sanofi (France)
Eli Lilly and Company (U.S.)
Biocon Ltd. (India)
Julphar (U.A.E.)
Wockhardt Ltd.( India)
Biodel Inc. (U.S.)
Wanbang Biopharma Co. (China)
Dongbao Enterprise Group Co. (China)
Bioton (Poland)
Piramal Healthcare (India)
USV Limited (India)
Ganlee (China)

Market Segment by Regions, this report splits Global into several key countries, with sales (consumption), revenue, market share and growth rate of Insulin (Medication) in these countries, from 2011 to 2020 (forecast), like 
USA
China
EU
Japan
Southeast Asia
India
Rest of Global

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into 
Long-Acting Insulin
Rapid-Acting Insulin
Short-Acting Insulin
Intermediate-Acting Insulin
Premixed Insulin

Split by applications, this report focuses on consumption, market share and growth rate of Insulin (Medication) in each application, can be divided into
Type 1 Diabetes mellitus
Type 2 Diabetes mellitus

 Table of Contents
Global Insulin (Medication) Market Research Report to 2020 1 Insulin (Medication) Overview 1.1 Product Overview and Scope of Insulin (Medication) 1.2 Insulin (Medication) Segment by Type 1.2.1 Long-Acting Insulin and Sales Growth Rate 2011-2020 1.2.2 Rapid-Acting Insulin and Sales Growth Rate 2011-2020 1.2.3 Short-Acting Insulin and Sales Growth Rate 2011-2020 1.2.4 Intermediate-Acting Insulin and Sales Growth Rate 2011-2020 1.2.5 Premixed Insulin and Sales Growth Rate 2011-2020 1.3 Insulin (Medication) Segment by Applications 1.3.1 Insulin (Medication) Sales Market Share by Applications in 2015 and 2016 1.3.2 Type 1 Diabetes mellitus 1.3.3 Type 2 Diabetes mellitus 1.4 Insulin (Medication) Market by Regions 1.4.1 USA Status and Prospect 2011-2020 1.4.2 China Status and Prospect 2011-2020 1.4.3 EU Status and Prospect 2011-2020 1.4.4 Japan Status and Prospect 2011-2020 1.4.5 Southeast Asia Status and Prospect 2011-2020 1.4.6 India Status and Prospect 2011-2020 1.5 Global Market Size (Value and Volume) of Insulin (Medication) 2011-2020 1.5.1 Global Insulin (Medication) Sales and Growth Rate 2011-2020 1.5.2 Global Insulin (Medication) Revenue and Growth Rate 2011-2020 2 Global Insulin (Medication) Market Competition by Manufacturers 2.1 Global Insulin (Medication) Sales and Share by Manufacturers (2015 and 2016) 2.2 Global Insulin (Medication) Revenue and Share by Manufacturers (2015 and 2016) 2.3 Global Insulin (Medication) Average Price by Manufacturers (2015 and 2016) 2.4 Manufacturers Insulin (Medication) Manufacturing Base Distribution and Product Type 3 Global Insulin (Medication) Market Analysis by Type and Applications 3.1 Global Insulin (Medication) Sales, Market Share and Growth Rate by Type 2011-2020 3.2 Global Insulin (Medication) Revenue, Market Share and Growth Rate by Type 2011-2020 3.3 Insulin (Medication) Average Price by Type in 2015 3.4 Global Insulin (Medication) Sales, Market Share and Growth Rate by Applications 2011-2020 4 Global Insulin (Medication) Manufacturers Analysis 4.1 Novo Nordisk (Denmark) 4.1.1 Company Basic Information, Manufacturing Base and Competitors 4.1.2 Insulin (Medication) Product Type and Technology 4.1.2.1 NovaRapid/Novolog Price and Specification 4.1.2.2 Levemir Price and Specification 4.1.2.3 Human insulin Price and Specification 4.1.2.4 NovaMix Price and Specification 4.1.3 Insulin (Medication) Sales, Revenue, Price of Novo Nordisk 2015 to 2016 4.2 Sanofi (France) 4.2.1 Company Basic Information, Manufacturing Base and Competitors 4.2.2 Insulin (Medication) Product Type and Technology 4.2.2.1 Lantus Price and Specification 4.2.2.2 Apidra Price and Specification 4.2.2.3 Toujeo Price and Specification 4.2.2.4 Insuman Price and Specification 4.2.2.5 Aferzza Price and Specification 4.2.3 Insulin (Medication) Sales, Revenue, Price of Sanofi 2015 to 2016 4.3 Eli Lilly and Company (U.S.) 4.3.1 Company Basic Information, Manufacturing Base and Competitors 4.3.2 Insulin (Medication) Product Type and Technology 4.3.2.1 Humalog Price and Specification 4.3.2.2 Humanlin Price and Specification 4.3.2.3 Basaglar Price and Specification 4.3.3 Insulin (Medication) Sales, Revenue, Price of Eli Lilly and Company 2015 to 2016 4.4 Biocon Ltd. (India) 4.4.1 Company Basic Information, Manufacturing Base and Competitors 4.4.2 Insulin (Medication) Product Type and Technology 4.4.2.1 Recombinant Human Insulin (rh-Insulin) Price and Specification 4.4.2.2 Insulin Glargine Price and Specification 4.4.2.3 Insulin Aspart Price and Specification 4.4.2.4 Insulin Lispro Price and Specification 4.4.3 Insulin (Medication) Sales, Revenue, Price of Biocon Ltd. 2015 to 2016 4.5 Julphar (U.A.E.) 4.5.1 Company Basic Information, Manufacturing Base and Competitors 4.5.2 Insulin (Medication) Product Type and Technology 4.5.2.1 INSULIN (API) Price and Specification 4.5.2.2 JUSLINE 30/70 Price and Specification 4.5.2.3 JUSLINE N Price and Specification 4.5.2.4 JUSLINE R Price and Specification 4.5.3 Insulin (Medication) Sales, Revenue, Price of Julphar 2015 to 2016 4.6 Wockhardt Ltd.( India) 4.6.1 Company Basic Information, Manufacturing Base and Competitors 4.6.2 Insulin (Medication) Product Type and Technology 4.6.2.1 Wosulin Price and Specification 4.6.2.2 Glaritus Price and Specification 4.6.3 Insulin (Medication) Sales, Revenue, Price of Wockhardt Ltd. 2015 to 2016 4.7 Biodel Inc. (U.S.) 4.7.1 Company Basic Information, Manufacturing Base and Competitors 4.7.2 Insulin (Medication) Product Type and Technology 4.7.2.1 RHI-Based Ultra-Rapid-Acting Insulin Price and Specification 4.7.2.2 Analog-Based Ultra-Rapid-Acting Insulin Price and Specification 4.7.2.3 Concentrated Ultra-Rapid-Acting Insulin Price and Specification 4.7.3 Insulin (Medication) Sales, Revenue, Price of Biodel Inc. 2015 to 2016 4.8 Wanbang Biopharma Co. (China) 4.8.1 Company Basic Information, Manufacturing Base and Competitors 4.8.2 Insulin (Medication) Product Type and Technology 4.8.2.1 CLONEPO Price and Specification 4.8.2.2 CICLEADON Price and Specification 4.8.2.3 CLONGAMMA Price and Specification 4.8.3 Insulin (Medication) Sales, Revenue, Price of Wanbang Biopharma Co. 2015 to 2016 4.9 Dongbao Enterprise Group Co. (China) 4.9.1 Company Basic Information, Manufacturing Base and Competitors 4.9.2 Insulin (Medication) Product Type and Technology 4.9.2.1 Gansulin R Price and Specification 4.9.2.2 Gansulin N Price and Specification 4.9.2.3 Gansulin 30R Price and Specification 4.9.3 Insulin (Medication) Sales, Revenue, Price of Dongbao Enterprise Group Co. 2015 to 2016 4.10 Bioton (Poland) 4.10.1 Company Basic Information, Manufacturing Base and Competitors 4.10.2 Insulin (Medication) Product Type and Technology 4.10.2.1 Recombinant human insulin Price and Specification 4.10.3 Insulin (Medication) Sales, Revenue, Price of Bioton 2015 to 2016 4.11 Piramal Healthcare (India) 4.11.1 Company Basic Information, Manufacturing Base and Competitors 4.11.2 Insulin (Medication) Product Type and Technology 4.11.2.1 Actrapid 100iu/40iu Price and Specification 4.11.2.2 Actrapid HM Price and Specification 4.11.3 Insulin (Medication) Sales, Revenue, Price of PIRAMAL HEALTHCARE 2015 to 2016 4.12 USV Limited (India) 4.12.1 Company Basic Information, Manufacturing Base and Competitors 4.12.2 Insulin (Medication) Product Type and Technology 4.12.2.1 Pramlintide Price and Specification 4.12.3 Insulin (Medication) Sales, Revenue, Price of USV Limited 2015 to 2016 4.13 Ganlee (China) 4.13.1 Company Basic Information, Manufacturing Base and Competitors 4.13.2 Insulin (Medication) Product Type and Technology 4.13.2.1 Basalin Price and Specification 4.13.2.2 Prandilin Price and Specification 4.13.2.3 Prandilin 25R Price and Specification 4.13.3 Insulin (Medication) Sales, Revenue, Price of Ganlee 2015 to 2016 5 Global Insulin (Medication) Market Analysis by Regions 5.1 USA Insulin (Medication) Market 5.1.1 USA Insulin (Medication) Sales, Revenue and Growth Rate 2011-2020 5.1.2 USA Insulin (Medication) Sales and Market Share by Manufacturers in 2015 5.1.3 USA Insulin (Medication) Sales and Market Share by Type in 2015 5.1.4 USA Insulin (Medication) Sales and Market Share by Applications in 2015 5.2 China Insulin (Medication) Market 5.2.1 China Insulin (Medication) Sales, Revenue and Growth Rate 2011-2020 5.2.2 China Insulin (Medication) Sales and Market Share by Manufacturers in 2015 5.2.3 China Insulin (Medication) Sales and Market Share by Type in 2015 5.2.4 China Insulin (Medication) Sales and Market Share by Applications in 2015 5.3 EU Insulin (Medication) Market 5.3.1 EU Insulin (Medication) Sales, Revenue and Growth Rate 2011-2020 5.3.2 EU Insulin (Medication) Sales and Market Share by Manufacturers in 2015 5.3.3 EU Insulin (Medication) Sales and Market Share by Type in 2015 5.3.4 EU Insulin (Medication) Sales and Market Share by Applications in 2015 5.4 Japan Insulin (Medication) Market 5.4.1 Japan Insulin (Medication) Sales, Revenue and Growth Rate 2011-2020 5.4.2 Japan Insulin (Medication) Sales and Market Share by Manufacturers in 2015 5.4.3 Japan Insulin (Medication) Sales and Market Share by Type in 2015 5.4.4 Japan Insulin (Medication) Sales and Market Share by Applications in 2015 5.5 Southeast Asia Insulin (Medication) Market 5.5.1 Southeast Asia Insulin (Medication) Sales, Revenue and Growth Rate 2011-2020 5.5.2 Southeast Asia Insulin (Medication) Sales and Market Share by Manufacturers in 2015 5.5.3 Southeast Asia Insulin (Medication) Sales and Market Share by Type in 2015 5.5.4 Southeast Asia Insulin (Medication) Sales and Market Share by Applications in 2015 6 Insulin (Medication) Technology and Development Trend 6.1 Insulin (Medication) Technology Analysis 6.1.1 Research Progress of Inhaled Insulin 6.1.1.1 Inhaled Insulin Products in Research or in Clinical Trial 6.1.1.2 Development Trend for Inhaled Insulin 6.1.2 Research Progress of Oral Insulin 6.1.2.1 Oral Insulin Products in Research or in Clinical Trial 6.1.2.2 Development Trend Oral Insulin 6.1.3 Research Progress of Other New Insulin 6.1.4 Development of Insulin Devices 6.2 Insulin (Medication) Technology Development Trend 7 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Insulin (Medication) Figure Picture of Long-Acting Insulin Figure Long-Acting Insulin Sales Growth Rate 2011-2020 Figure Picture of Rapid-Acting Insulin Figure Rapid-Acting Insulin Sales Growth Rate 2011-2020 Figure Picture of Short-Acting Insulin Figure Short-Acting Insulin Sales Growth Rate 2011-2020 Figure Picture of Intermediate-Acting Insulin Figure Intermediate-Acting Insulin Sales Growth Rate 2011-2020 Figure Picture of Premixed Insulin Figure Premixed Insulin Sales Growth Rate 2011-2020 Table Insulin (Medication) Sales Market Share by Applications in 2015 and 2016 Table Insulin (Medication) Key Clients (Buyers) List in Type 1 Diabetes mellitus Table Insulin (Medication) Key Clients (Buyers) List in Type 2 Diabetes mellitus Figure USA Insulin (Medication) Sales and Growth Rate 2011-2020 Figure China Insulin (Medication) Sales and Growth Rate 2011-2020 Figure EU Insulin (Medication) Sales and Growth Rate 2011-2020 Figure Japan Insulin (Medication) Sales and Growth Rate 2011-2020 Figure Southeast Asia Insulin (Medication) Sales and Growth Rate 2011-2020 Figure India Insulin (Medication) Sales and Growth Rate 2011-2020 Figure Global Insulin (Medication) Sales and Growth Rate 2011-2020 Figure Global Insulin (Medication) Revenue and Growth Rate 2011-2020 Table Global Insulin (Medication) Sales of Key Manufacturers (2015 and 2016) Table Global Insulin (Medication) Sales Share by Manufacturers (2015 and 2016) Table Global Insulin (Medication) Revenue by Manufacturers (2015 and 2016) Table Global Insulin (Medication) Revenue Share by Manufacturers (2015 and 2016) Table Global Market Insulin (Medication) Average Price of Key Manufacturers (2015 and 2016) Table Manufacturers Insulin (Medication) Manufacturing Base Distribution and Product Type Table Global Insulin (Medication) Sales by Type 2011-2020 Table Global Insulin (Medication) Sales Share by Type 2011-2020 Table Global Insulin (Medication) Sales Growth Rate by Type 2011-2020 Table Global Insulin (Medication) Revenue by Type 2011-2020 Table Global Insulin (Medication) Revenue Share by Type 2011-2020 Table Global Insulin (Medication) Revenue Growth Rate by Type 2011-2020 Table Insulin (Medication) Average Price by Type in 2015 Table Global Insulin (Medication) Sales by Type 2 Diabetes mellitus011-2020 Table Global Insulin (Medication) Sales Market Share by Type 2 Diabetes mellitus011-2020 Table Global Insulin (Medication) Sales Growth Rate by Type 2 Diabetes mellitus011-2020 Table Novo Nordisk Basic Information List Table Insulin (Medication) Sales, Revenue, Price of Novo Nordisk 2015 to 2016 Table Sanofi Basic Information List Table Insulin (Medication) Sales, Revenue, Price of Sanofi 2015 to 2016 Table Eli Lilly and Company Basic Information List Table Insulin (Medication) Sales, Revenue, Price of Eli Lilly and Company 2015 to 2016 Table Biocon Ltd. Basic Information List Table Insulin (Medication) Sales, Revenue, Price of Biocon Ltd. 2015 to 2016 Table Julphar Basic Information List Table Insulin (Medication) Sales, Revenue, Price of Julphar 2015 to 2016 Table Wockhardt Ltd. Basic Information List Table Insulin (Medication) Sales, Revenue, Price of Wockhardt Ltd. 2015 to 2016 Table Biodel Inc. Basic Information List Table Insulin (Medication) Sales, Revenue, Price of Biodel Inc. 2015 to 2016 Table Wanbang Biopharma Co. Basic Information List Table Insulin (Medication) Sales, Revenue, Price of Wanbang Biopharma Co. 2015 to 2016 Table Dongbao Enterprise Group Co. Basic Information List Table Insulin (Medication) Sales, Revenue, Price of Dongbao Enterprise Group Co. 2015 to 2016 Table Bioton Basic Information List Table Insulin (Medication) Sales, Revenue, Price of Bioton 2015 to 2016 Table PIRAMAL HEALTHCARE Basic Information List Table Insulin (Medication) Sales, Revenue, Price of PIRAMAL HEALTHCARE 2015 to 2016 Table USV Limited Basic Information List Table Insulin (Medication) Sales, Revenue, Price of USV Limited 2015 to 2016 Table Ganlee Basic Information List Table Insulin (Medication) Sales, Revenue, Price of Ganlee 2015 to 2016 Figure USA Insulin (Medication) Sales and Growth Rate 2011-2020 Figure USA Insulin (Medication) Revenue and Growth Rate 2011-2020 Table USA Insulin (Medication) Sales and Market Share by Manufacturers in 2015 Table USA Insulin (Medication) Sales and Market Share by Type in 2015 Table USA Insulin (Medication) Sales and Market Share by Applications in 2015 Figure China Insulin (Medication) Sales and Growth Rate 2011-2020 Figure China Insulin (Medication) Revenue and Growth Rate 2011-2020 Table China Insulin (Medication) Sales and Market Share by Manufacturers in 2015 Table China Insulin (Medication) Sales and Market Share by Type in 2015 Table China Insulin (Medication) Sales and Market Share by Applications in 2015 Figure EU Insulin (Medication) Sales and Growth Rate 2011-2020 Figure EU Insulin (Medication) Revenue and Growth Rate 2011-2020 Table EU Insulin (Medication) Sales and Market Share by Manufacturers in 2015 Table EU Insulin (Medication) Sales and Market Share by Type in 2015 Table EU Insulin (Medication) Sales and Market Share by Applications in 2015 Figure Japan Insulin (Medication) Sales and Growth Rate 2011-2020 Figure Japan Insulin (Medication) Revenue and Growth Rate 2011-2020 Table Japan Insulin (Medication) Sales and Market Share by Manufacturers in 2015 Table Japan Insulin (Medication) Sales and Market Share by Type in 2015 Table Japan Insulin (Medication) Sales and Market Share by Applications in 2015 Figure Southeast Asia Insulin (Medication) Sales and Growth Rate 2011-2020 Figure Southeast Asia Insulin (Medication) Revenue and Growth Rate 2011-2020 Table Southeast Asia Insulin (Medication) Sales and Market Share by Manufacturers in 2015 Table Southeast Asia Insulin (Medication) Sales and Market Share by Type in 2015 Table Southeast Asia Insulin (Medication) Sales and Market Share by Applications in 2015



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global non halogenated flame retardants market size is anticipated to be valued at USD 2.54 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing safety materials demand owing to low heat & smoke emission properties in c

Read More...

North America air conditioner market size is expected to be valued at USD 52,560.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing usage of energy efficient air conditioners owing to declining energy consumption rat

Read More...

Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.

Read More...

Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demand

Read More...

Global gas sensors market is expected to reach USD 2,512.4 million by 2020, as per a new research report by Radiant Insights, Inc. High adoption rate of wireless and smart gas sensor technology coupled with escalating demand from end-use industries s

Read More...
Choose License Type
Single User - US $2650
Multi User - US $5300
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify